ICR Acquires Westwicke Partners, North America’s Leading Healthcare-Focused IPO Advisor & Investor Relations Firm. Learn More

Westicke Partners

Mobile Navigation

Chris Gardner, PhD

Chris has more than 15 years’ experience in strategic communications from across the healthcare sector and has worked with companies at all stages of development including for some of the world’s leading pharmaceutical and biotechnology companies.

Biography

Chris has more than 15 years’ experience in strategic communications from across the healthcare sector and has worked with companies at all stages of development including for some of the world’s leading pharmaceutical and biotechnology companies. He has led communications strategies on multiple cross-border IPOs, private fundraisings and international M&A. His corporate communication experience includes extensive profile raising campaigns to support companies’ business objectives and crisis communication.

Chris was formerly a Director in the Life Sciences team at Citigate Dewe Rogerson where he worked from 2003 to 2015 and an Associate Director at former specialist bioscience communications consultancy, HCC De Facto. He has degrees in Biological Sciences and Psychology, a background in journalism and a PhD in molecular biology.

Read about Westwicke’ joint venture with European partner, Consilium Strategic Communications >>

ICR ACQUIRES WESTWICKE PARTNERS

Westwicke will operate as ICR’s healthcare practice and integrate ICR’s capabilities. Read more in the press release announcement.

Our Locations